Metagenomi Aktie
WKN DE: A4021A / ISIN: US59102M1045
|
17.03.2025 21:15:32
|
Metagenomi, Inc. Full Year Sales Increase
(RTTNews) - Metagenomi, Inc. (MGX) revealed Loss for full year of -$78.06 million
The company's earnings came in at -$78.06 million, or -$2.36 per share. This compares with -$68.26 million, or -$20.05 per share, last year.
The company's revenue for the period rose 16.8% to $52.30 million from $44.76 million last year.
Metagenomi, Inc. earnings at a glance (GAAP) :
-Earnings: -$78.06 Mln. vs. -$68.26 Mln. last year. -EPS: -$2.36 vs. -$20.05 last year. -Revenue: $52.30 Mln vs. $44.76 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Metagenomi Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Metagenomi Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| Metagenomi Inc Registered Shs | 1,51 | 0,00% |
|